Internal Medicine, Cardiovascular Disease · Cincinnati, OH
NPI
1326281007
Since 2009
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3219 Clifton Ave Ste 400
Cincinnati, OH, 45220
Phone (513) 569-6647
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
2,731 services
Medicare patients, 2024
1,278
Average age 76
Drug cost, 2024
$4.5M
4,351 prescriptions
Company payments, 2025
$46K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kamal Shemisa was code 99214 (office e&m - established), 597 times for 379 patients. In total Kamal Shemisa billed 2,731 services in 37 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 597 | 379 | $84.14 | $50K |
| 93010 Electrocardiogram | Facility | 570 | 477 | $6.16 | $3,509 |
| 93000 Electrocardiogram | Office | 291 | 270 | $9.57 | $2,783 |
| 93306 Echocardiography (TTE/TEE) | Facility | 215 | 214 | $47.90 | $10K |
| 99223 Hospital E&M - Initial | Facility | 133 | 129 | $130.44 | $17K |
| 93308 Echocardiography (TTE/TEE) | Facility | 102 | 97 | $18.35 | $1,872 |
| 93325 Echocardiography (TTE/TEE) | Facility | 98 | 95 | $2.31 | $226 |
| 93321 Echocardiography (TTE/TEE) | Facility | 83 | 80 | $5.30 | $440 |
| 99215 Office E&M - Established | Office | 71 | 62 | $128.94 | $9,154 |
| 93016 Electrocardiogram | Facility | 71 | 70 | $15.23 | $1,081 |
| 93018 Electrocardiogram | Facility | 71 | 70 | $10.08 | $716 |
| 99233 Hospital E&M - Subsequent | Facility | 69 | 42 | $90.34 | $6,234 |
| 99204 Office E&M - New | Office | 40 | 40 | $119.50 | $4,780 |
| 99222 Hospital E&M - Initial | Facility | 36 | 35 | $101.79 | $3,665 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 24 | $61.71 | $2,222 |
By year: 2022 $153K for 3,375 services; 2023 $128K for 3,139 services; 2024 $127K for 2,731 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kamal Shemisa prescribed most often to Medicare patients was Ozempic (Semaglutide), with 350 prescriptions and refills. In total Kamal Shemisa wrote 4,351 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 350 | 422 | 84 | $365K |
| Spironolactone Generic | 337 | 779 | 122 | $1,966 |
| Rosuvastatin Calcium Generic | 253 | 624 | 99 | $2,471 |
| Jardiance Empagliflozin | 252 | 434 | 84 | $218K |
| Metoprolol Succinate Generic | 242 | 600 | 102 | $2,451 |
| Ezetimibe Generic | 238 | 599 | 95 | $4,677 |
| Atorvastatin Calcium Generic | 162 | 408 | 66 | $1,129 |
| Eliquis Apixaban | 149 | 293 | 48 | $166K |
| Wegovy Semaglutide | 136 | 141 | 27 | $188K |
| Lisinopril Generic | 130 | 354 | 63 | $611 |
| Carvedilol Generic | 127 | 293 | 48 | $750 |
| Losartan Potassium Generic | 120 | 265 | 36 | $704 |
| Farxiga Dapagliflozin Propanediol | 119 | 187 | 35 | $92K |
| Xarelto Rivaroxaban | 113 | 216 | 37 | $121K |
| Amlodipine Besylate Generic | 107 | 272 | 46 | $436 |
Brand drugs: - claims; generic drugs: 2,628 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kamal Shemisa $46K ($46K in general payments such as food, travel and fees) from 21 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $22K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 25 | $22K |
| Pfizer Inc. PFE | 17 | $13K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $8,150 |
| Lilly USA, LLC LLY | 1 | $1,430 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $391 |
| AOP Health US, LLC | 1 | $354 |
| Novo Nordisk Inc NVO | 6 | $295 |
| Abbott Laboratories ABT | 2 | $154 |
| Heartflow, Inc. HTFL | 2 | $149 |
| Merck Sharp & Dohme LLC MRK | 10 | $141 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.